The Vanguard Group 13D and 13G filings for Ginkgo Bioworks Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-01-30 9:58 pm Sale |
2024-12-31 | 13G | Ginkgo Bioworks Holdings, Inc. DNA |
The Vanguard Group | 2,013,548 4.450% |
-592,205 (-22.73%) |
Filing |
| 2024-11-12 3:58 pm Unchanged |
2024-09-30 | 13G | Ginkgo Bioworks Holdings, Inc. DNA |
The Vanguard Group | 2,605,753 6.040% |
0 (Unchanged) |
Filing |
| 2024-11-04 11:56 am Purchase |
2024-09-30 | 13G | Ginkgo Bioworks Holdings, Inc. DNA |
The Vanguard Group | 2,605,753 6.040% |
2,605,753 (New Position) |
Filing |